AzTrials
AzTrials

Conductive Hearing LossCone-BeamNCT06164184

Interest of the Cone Beam Scanner of Temporal Bones in the Analysis of Conductive Hearing Loss

An observational study of Conductive Hearing Loss, run by University Hospital, Strasbourg, France at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Conductive hearing loss is very common and the incidence increases with age. Until now, the scanner was the reference examination in the etiological diagnosis of deafness. When performing a CT scan of temporal bones for the etiological diagnosis of conductive hearing loss, the quality of the image depends on the… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Conductive Hearing Loss
How many people
100 participants
Where
1 siteFrance
Study dates
1 Oct 2020to 31 Dec 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Major subject (≥18 years old) having performed a CT scan or a cone beam for pre- and post-operative conductive hearing loss between January 01, 2018 and December 31, 2020

Who may be able to join

  • Major subject (≥18 years old)
  • Subject having performed a CT scan or a cone beam for pre- and post-operative conductive hearing loss between January 01, 2018 and December 31, 2020
  • Subject who has not expressed his opposition, after being informed, to the reuse of his data for the purposes of this research.

Who cannot join

  • Subject who expressed their opposition to participating in the study

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Service de Radiologie 1 - CHU de Strasbourg - France

    Strasbourg, 67091

    Francis VEILLON, MD, PhD, 33 3 88 12 78 65, francis.veillon@chru-strasbourg.fr

    Francis VEILLON, MD, PhD

    Recruiting

Other trials in France

About this study

Conductive hearing loss is very common and the incidence increases with age. Until now, the scanner was the reference examination in the etiological diagnosis of deafness.

When performing a CT scan of temporal bones for the etiological diagnosis of conductive hearing loss, the quality of the image depends on the scanner brand and the acquisition parameters.

The investigators wish to show the usefulness of the cone beam in the diagnosis of conductive hearing loss

Keywords
Conductive Hearing Loss, Cone Beam, Cone beam CT, CBCT, Temporal bones
Medical subject headings
Hearing Loss, Conductive

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Show retrospectively that the superiority of the cone beam over the scanner in the diagnosis of conductive hearing loss

    This superiority is based on the quality of the images allowing the visualization of the different elements of the middle and inner ears:

    Ossicles, windows, nerves (VII and VIII), cochlea, labyrinth

    Measured: Files analysed retrospectively from January 01, 2018 to December 31, 2020 will be examined

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Dec 2023
  2. Study start1 Oct 2020
  3. Primary completionDec 2023 (estimated)
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Retrospective
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06164184
Sponsor's protocol ID
8012
Acronym
Cone-Beam
Status last verified
Dec 2023
First submitted
29 Nov 2022
Last updated
11 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Conductive Hearing Loss, run by University Hospital, Strasbourg, France at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Francis VEILLON, MD, PhD (33 3 88 12 78 65, francis.veillon@chru-strasbourg.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Show retrospectively that the superiority of the cone beam over the scanner in the diagnosis of conductive hearing loss (time frame: Files analysed retrospectively from January 01, 2018 to December 31, 2020 will be examined). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in